Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.
Blood. 2002 Mar 15;99(6):1928-37. doi: 10.1182/blood.v99.6.1928.
Blood. 2002.
PMID: 11877262
Free article.
Clinical Trial.
Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy.
Atallah E, Talpaz M, O'brien S, Rios MB, Guo JQ, Arlinghaus R, Fernandes-Reese S, Kantarjian H.
Atallah E, et al. Among authors: fernandes reese s.
Cancer. 2002 Jun 1;94(11):2996-9. doi: 10.1002/cncr.10576.
Cancer. 2002.
PMID: 12115389
Free article.
Item in Clipboard
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT, Tura S, Fischer T, Deininger MW, Schiffer CA, Baccarani M, Gratwohl A, Hochhaus A, Hoelzer D, Fernandes-Reese S, Gathmann I, Capdeville R, O'Brien SG.
Ottmann OG, et al. Among authors: fernandes reese s.
Blood. 2002 Sep 15;100(6):1965-71. doi: 10.1182/blood-2001-12-0181.
Blood. 2002.
PMID: 12200353
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite